Phase 1 Study of JLP-2302 and JP-1366: PK and Safety in Healthy Volunteers

by palligoelme@gmail.com | Sep 18, 2025 | Clinical Trials

​ Conditions: Healthy Interventions: Drug: JLP-2302; Drug: JP-1366 Sponsors: Onconic Therapeutics Inc. Completed Conditions: Healthy Interventions: Drug: JLP-2302; Drug: JP-1366 Sponsors: Onconic Therapeutics Inc....

Trastuzumab Deruxtecan in Advanced Breast Cancer

by palligoelme@gmail.com | Sep 18, 2025 | Clinical Trials

​ Conditions: Advanced Breast Cancer Interventions: Drug: Trastuzumab deruxtecan Sponsors: Wenjin Yin Not yet recruiting Conditions: Advanced Breast Cancer Interventions: Drug: Trastuzumab deruxtecan Sponsors: Wenjin Yin Not yet...

High-Frequency vs. Theta-Burst TMS for Depression: Double-Blind RCT

by palligoelme@gmail.com | Sep 18, 2025 | Clinical Trials

​ Conditions: Major Depression Interventions: Device: High-frequency repetitive transcranial magnetic stimulation; Device: Intermittent Theta Burst Stimulation Sponsors: Krajská zdravotní, a.s. – Nemocnice Most, o.z. Completed Conditions: Major Depression...

The Validity and Reliability of an Improved Paper Grasping Test for Stroke

by palligoelme@gmail.com | Sep 18, 2025 | Clinical Trials

​ Conditions: Stroke; Balance; Validity and Safety Sponsors: Sanko University Completed Conditions: Stroke; Balance; Validity and Safety Sponsors: Sanko University Completed 

Preeclampsia and Defective Placentation in Oocyte Donation: Importance of HLA-C and KIR

by palligoelme@gmail.com | Sep 17, 2025 | Clinical Trials

​ Conditions: Preeclampsia (PE) Risk; Oocyte Donation Sponsors: Universitair Ziekenhuis Brussel Not yet recruiting Conditions: Preeclampsia (PE) Risk; Oocyte Donation Sponsors: Universitair Ziekenhuis Brussel Not yet recruiting